AI Assistant
Blog
Pricing
Log In
Sign Up
181 Efficacy and safety of ixekizumab at week 52 in biologic naïve patients with active psoriatic arthritis (SPIRIT-P1)
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
